Related Experiment Videos
Transforming growth factor-beta and prostate cancer
1Department of Urology and Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
World Journal of Urology
|January 1, 1995
Summary
Transforming growth factor-beta 1 (TGFbeta1) paradoxically promotes prostate cancer growth by making cancer cells resistant to its inhibitory effects and aiding tumor progression. This protein also suppresses immune responses and enhances metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGFbeta) isoforms 1-3 play complex roles in cellular processes.
- TGFbeta1 normally inhibits prostate cell proliferation but is overexpressed in prostate cancer.
Purpose of the Study:
- To review the multifaceted role of TGFbeta isoforms in prostate cancer development and progression.
- To elucidate the paradox of TGFbeta1 overexpression in prostate cancer despite its inhibitory function in normal cells.
Main Methods:
- Literature review of studies investigating TGFbeta isoforms in prostate cancer.
- Analysis of signaling pathway aberrations affecting TGFbeta1 sensitivity.
- Examination of TGFbeta1's indirect effects on tumor microenvironment and host factors.
Main Results:
- Prostate cancer cells develop resistance to TGFbeta1's growth-inhibitory effects during tumor progression.
- Aberrations in the TGFbeta1 signaling pathway contribute to this resistance.
- Elevated TGFbeta1 levels may promote tumor growth by immune suppression, angiogenesis, and enhanced metastasis.
Conclusions:
- TGFbeta1 is implicated in prostate carcinogenesis and tumorigenicity.
- TGFbeta1's dual role involves direct and indirect mechanisms promoting prostate cancer.
- The roles of TGFbeta2 and TGFbeta3 in prostate cancer require further investigation.